Literature DB >> 22825673

Lupus nephritis: Implications of the new ACR lupus nephritis guidelines.

Hans-Joachim Anders1, Gerald B Appel.   

Abstract

The American College of Rheumatology recently published guidelines for the screening, treatment, and management of lupus nephritis. How will or should these guidelines impact our current daily practice?

Entities:  

Mesh：

Year:  2012        PMID： 22825673     DOI： 10.1038/nrneph.2012.162

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  9 in total

1.  The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials.

Authors: 
Journal:  Arthritis Rheum       Date:  2006-02

2.  American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.

Authors:  Bevra H Hahn; Maureen A McMahon; Alan Wilkinson; W Dean Wallace; David I Daikh; John D Fitzgerald; George A Karpouzas; Joan T Merrill; Daniel J Wallace; Jinoos Yazdany; Rosalind Ramsey-Goldman; Karandeep Singh; Mazdak Khalighi; Soo-In Choi; Maneesh Gogia; Suzanne Kafaja; Mohammad Kamgar; Christine Lau; William J Martin; Sefali Parikh; Justin Peng; Anjay Rastogi; Weiling Chen; Jennifer M Grossman
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-06       Impact factor: 4.794

3.  Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

Authors:  Ellen M Ginzler; Mary Anne Dooley; Cynthia Aranow; Mimi Y Kim; Jill Buyon; Joan T Merrill; Michelle Petri; Gary S Gilkeson; Daniel J Wallace; Michael H Weisman; Gerald B Appel
Journal:  N Engl J Med       Date:  2005-11-24       Impact factor: 91.245

4.  Assessment of a lupus nephritis cohort over a 30-year period.

Authors:  Sara C Croca; Teresa Rodrigues; David A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2011-03-16       Impact factor: 7.580

5.  Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.

Authors:  Mary Anne Dooley; David Jayne; Ellen M Ginzler; David Isenberg; Nancy J Olsen; David Wofsy; Frank Eitner; Gerald B Appel; Gabriel Contreras; Laura Lisk; Neil Solomons
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

6.  European consensus statement on the terminology used in the management of lupus glomerulonephritis.

Authors:  C Gordon; D Jayne; C Pusey; D Adu; Z Amoura; M Aringer; J Ballerin; R Cervera; J Calvo-Alén; C Chizzolini; Jm Dayer; A Doria; F Ferrario; J Floege; L Guillevin; M Haubitz; F Hiepe; F Houssiau; P Lesavre; L Lightstone; Pl Meroni; O Meyer; B Moulin; K O'Reilly; M Praga; H Schulze-Koops; Ra Sinico; Kgc Smith; A Tincani; C Vasconcelos; G Hughes
Journal:  Lupus       Date:  2009-03       Impact factor: 2.911

7.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

8.  Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Authors:  Gerald B Appel; Gabriel Contreras; Mary Anne Dooley; Ellen M Ginzler; David Isenberg; David Jayne; Lei-Shi Li; Eduardo Mysler; Jorge Sánchez-Guerrero; Neil Solomons; David Wofsy
Journal:  J Am Soc Nephrol       Date:  2009-04-15       Impact factor: 10.121

9.  Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Authors:  Frédéric A Houssiau; David D'Cruz; Shirish Sangle; Philippe Remy; Carlos Vasconcelos; Radmila Petrovic; Christoph Fiehn; Enrique de Ramon Garrido; Inge-Magrethe Gilboe; Maria Tektonidou; Daniel Blockmans; Isabelle Ravelingien; Véronique le Guern; Geneviève Depresseux; Loïc Guillevin; Ricard Cervera
Journal:  Ann Rheum Dis       Date:  2010-09-10       Impact factor: 19.103
  9 in total
  7 in total

1.  RORγt expression in Tregs promotes systemic lupus erythematosus via IL-17 secretion, alteration of Treg phenotype and suppression of Th2 responses.

Authors:  M A Kluger; A Nosko; T Ramcke; B Goerke; M C Meyer; C Wegscheid; M Luig; G Tiegs; R A K Stahl; O M Steinmetz
Journal:  Clin Exp Immunol       Date:  2017-01-05       Impact factor: 4.330

Review 2.  The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.

Authors:  Xiaoyan Zhang; Ling Ji; Lichuan Yang; Xiaohong Tang; Wei Qin
Journal:  Int Urol Nephrol       Date:  2016-01-19       Impact factor: 2.370

3.  Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse.

Authors:  Lunhua Liu; Windy Rose Allman; Adam Steven Coleman; Kazuyo Takeda; Tsai-Lien Lin; Mustafa Akkoyunlu
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

4.  Interleukin-7 receptor single nucleotide polymorphism rs6897932 (C/T) and the susceptibility to systemic lupus erythematosus.

Authors:  Xiao-Song Wang; Peng-Fei Wen; Min Zhang; Lin-Feng Hu; Jing Ni; Li-Juan Qiu; Yan Liang; Wei Zhao; Qing Huang; Sha-Sha Tao; Wang-Dong Xu; Chen-Chen Feng; Han Cen; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

5.  Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest Pediatric Nephrology Consortium and the Childhood Arthritis and Rheumatology Research Alliance.

Authors:  Scott E Wenderfer; Jerome C Lane; Ibrahim F Shatat; Emily von Scheven; Natasha M Ruth
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-19       Impact factor: 3.054

6.  Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus.

Authors:  Honglin Zhu; Wentao Mi; Hui Luo; Tao Chen; Shengxi Liu; Indu Raman; Xiaoxia Zuo; Quan-Zhen Li
Journal:  Arthritis Res Ther       Date:  2016-07-13       Impact factor: 5.156

7.  Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report.

Authors:  Narges E Omran; Abdulsalam A Noorwali
Journal:  Int J Gen Med       Date:  2018-04-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.